LifePro Asset Management’s AbbVie ABBV Stock Holding History

LifePro Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$275K	Buy	1,394 +56	+4%	+$10.5K	0.17%	118
2024 Q2	$229K	Sell	1,338 -23	-2%	-$3.81K	0.16%	116
2024 Q1	$248K	Buy	+1,361	New	+$235K	0.16%	112
2022 Q3	–	Sell	-3,027	Closed	-$464K	–	78
2022 Q2	$464K	Buy	3,027 +1,646	+119%	+$252K	0.24%	71
2022 Q1	$224K	Sell	1,381 -621	-31%	-$90.2K	0.08%	114
2021 Q4	$271K	Buy	+2,002	New	+$236K	0.08%	107

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

LifePro Asset Management's ABBV Position: Q3 2024 in Review

LifePro Asset Management increased its AbbVie (ABBV) stake by 4.2% in Q3 2024, buying an estimated $10.5K and bringing the position to 1,394 shares worth $275K. The position accounts for 0.17% of the portfolio, ranked #118.

LifePro Asset Management first reported a position in ABBV in Q4 2021 and has held it in 6 quarters since. The position peaked at $464K in Q2 2022. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

LifePro Asset Management held 1,394 shares of AbbVie worth $275K as of Q3 2024.
LifePro Asset Management bought 56 AbbVie shares in Q3 2024, an estimated $10.5K.
AbbVie made up 0.17% of LifePro Asset Management's portfolio in Q3 2024, its #118 holding.
LifePro Asset Management first reported a position in AbbVie in Q4 2021 and has held it in 6 quarters since.
LifePro Asset Management's AbbVie position peaked at $464K in Q2 2022.
3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on LifePro Asset Management's 13F filing for Q3 2024, filed 9 Oct 2024.